白虎汤加生黄芪治疗顽固性肝癌癌性发热35例  

Treatment of 35 Cases of Obstinate Liver Cancer Fever with "Baihu Decoction" and Raw Astragalus

作　　者：胡侠 周岳进 胡操寒 肖扬 郑金莉 张文静 卢成鸿 潘华将 

机构地区：[1]解放军118医院肝病科,浙江温州325000

出　　处：《上海中医药杂志》2009年第12期29-30,共2页Shanghai Journal of Traditional Chinese Medicine

摘　　要：目的观察白虎汤加生黄芪治疗顽固性肝癌癌性发热的临床疗效。方法采用随机对照方法将65例患者分为治疗组(35例)和对照组(30例),治疗组以白虎汤加生黄芪治疗,对照组以消炎痛栓剂纳肛治疗。两组均以7d为1个疗程,观察退热疗效,并在停药7d、14d时观察患者发热情况,同时观察两组不良反应的发生率。结果两组退热有效率分别为94.2%和66.6%,差异有统计学意义(P<0.01);治疗组停药后7d、14d时发热复发率分别为14.28%、5.7%,对照组分别为66.6%、50.0%,两组比较差异有统计学意义(P<0.01)。治疗组观察期间未见明显不良反应。结论白虎汤加生黄芪治疗顽固性肝癌癌性发热,退热作用持久而稳定,无明显不良反应。Objective To observe the clinical efficacy of ＂Baibu Decoction＂ and Astragalus in the treatment of obstinate liver cancer fever. Methods A randomized controlled method was adopted to divide 65 patients into treatment group（35 cases） and control group（30 cases） ; treatment group was given ＂Baihu Decoction＂ and Astmgalus, and control group was given indomethacin suppository, with a course of 7 days. The fever was observed instantly after treatment, 7 days and 14 days after treatment respectively. Meanwhile, the adverse reactions were observed. Results The effective rate of fever relief was 94.2% in the treatment group and 66.6% in the control group, with a significant difference（ P 〈0.01） ; in the treatment group the relapse rates were 14.28% and 5.7% respectively 7 days and 14 days after treatments, lower than 66.6% and 50% in the control group（ P 〈0.01 ） ; no adverse reactions were found in the treatment group. Conclusion ＂Baihu Decoction＂ and Astragalus is effective for liver cancer fever, without any adverse reactions.

关 键 词：肝癌 癌性发热 中医药疗法 

分 类 号：R273[医药卫生—中西医结合]